Skin Pain and Wegovy: What's Normal, What Isn't, and When to Act

Step 1, What happens at the injection site straight away

The pre-filled Wegovy pen deposits semaglutide into the fatty tissue just beneath the skin. Most people notice a brief sharp sting as the needle goes in, followed by a dull ache or warmth that spreads across a centimetre or two of skin. This is simply the tissue responding to the fluid being introduced. For the majority of people, it fades within minutes to a few hours. Some notice a small raised bump, a patch of redness, or mild bruising, all of which fall within the range that the NHS medicine guidance for semaglutide describes as common injection-site reactions.

A question our prescribers hear most weeks is whether the pain at the site means the injection has gone wrong. Almost always, it hasn't. Slight discomfort is expected, particularly at the 0.25mg starting dose when technique is still being established. Letting the pen warm to room temperature for around 30 minutes before injecting can take the edge off the sting. The patient information leaflet inside the box covers technique in detail and is worth reading alongside any guidance your prescribing team has given you.

What you should not see: swelling larger than roughly a 50p piece, pain that worsens over several hours rather than easing, skin that feels hot to the touch beyond the immediate area, or streaking redness that extends outward. Those patterns need same-day attention from a clinician.

Step 2, The days after an injection and skin reactions that can develop

Some skin reactions with Wegovy appear a day or so after the dose, rather than immediately. Itching around the site, a flat red patch, or a faint hive-like wheal can all occur as a delayed response. These are generally mild and resolve on their own within a couple of days. Applying a cool, clean cloth to the area helps with localised discomfort. Avoid rubbing the site vigorously straight after injecting.

Repeated injections into exactly the same spot over many weeks can lead to a condition called lipohypertrophy, a firmer, slightly raised area of fatty tissue that builds up from accumulated subcutaneous trauma. It is not dangerous in itself, but it changes how the medicine is absorbed, which can affect how well treatment is working. This is the main reason rotation matters. If you notice a persistent firm lump under the skin that hasn't resolved after several weeks, mention it at your next clinical review. You can find more detail on how Wegovy interacts with skin more broadly, including lipohypertrophy and rotation guidance.

Dry skin is a less-discussed but not uncommon experience during treatment. Appetite suppression sometimes leads to reduced calorie and fluid intake; lower hydration levels can leave skin feeling tighter and more sensitive. There is a dedicated look at Wegovy and dry skin for anyone finding this a persistent issue.

Step 3, Distinguishing a minor reaction from something that needs review

The clearest way to think about this is duration and spread. A normal injection-site reaction stays local and improves within 48 hours. Anything that grows, worsens, or develops new features (spreading redness, warmth tracking away from the site, fever, or pus) falls outside that pattern and needs prompt clinical assessment to rule out a skin infection.

Severe or widespread skin reactions can occasionally indicate an allergic response to semaglutide itself rather than just local trauma. Signs that raise that concern include hives appearing across a wider area, facial swelling, difficulty breathing, or a feeling of faintness after injecting. These require emergency care, not a wait-and-see approach.

If the pain is not at the skin surface but deeper (a muscular ache around the injection leg, or discomfort elsewhere in the body) the cause is different. Wegovy-related leg pain is a separate topic; the mechanism and advice differ from injection-site skin reactions. Similarly, if the discomfort presents as internal cramping or gastrointestinal pressure, that belongs to the gas-and-pain picture, not the skin-reaction picture.

The MHRA's Yellow Card scheme exists so that patients can report any suspected side effect, including skin reactions they feel were more than expected. Reporting helps regulators build a clearer picture of how Wegovy behaves in real-world use across the UK.

Step 4, Practical steps to reduce skin discomfort with each weekly dose

A few straightforward habits make a consistent difference. Remove the pen from the fridge roughly half an hour before you plan to inject; cold medicine stings noticeably more. Choose a different injection site each week, moving around the abdomen, upper thighs, and upper arms in rotation and avoiding the same spot within the same area for at least two weeks. Clean the skin with an alcohol swab and let it dry fully before inserting the needle; injecting through wet skin increases the likelihood of a sting.

Insert the needle at the angle described in the patient information leaflet and keep the pen pressed in until the dose counter returns to zero, then wait a further ten seconds before withdrawing. Pulling out too early is a common reason for incomplete injection and additional skin discomfort. Dispose of used needles in a sharps container, never recap or reuse them.

For context on what private treatment involves and how prescriptions are managed, the Wegovy treatment overview sets out the full picture, including eligibility and what the clinical process looks like. If you are considering whether private treatment is the right route, the weight-loss treatment overview explains the options available.

Worth knowing: skin reactions at the injection site, while real and sometimes uncomfortable, are not a reason to stop treatment without speaking to your prescribing team first. Many settle as the body adjusts over the first few weeks of the titration schedule.